Please assess the completion status of the following clinical trial:

Trial Title: Chemotherapy in Treating Children With Liver Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically proven hepatoblastoma or hepatocellular carcinoma~  * Diagnostic surgical biopsy strongly recommended for all patients and mandatory for the following:~    * Children under 6 months of age~   * Children over 3 years of age~   * Patients with a normal serum alfa-fetoprotein (alfa-FP)~ * Compatible imaging and raised serum alfa-FP level mandatory if no biopsy performed~* Standard risk disease:~  * Tumors involving no more than 3 hepatic sections~ * No extrahepatic abdominal disease~ * No metastases~* High risk disease:~  * Tumors involving all 4 hepatic sections AND/OR~ * Evidence of extrahepatic metastases or abdominal disease~* Presence or absence of metastatic disease must be documented by chest x-ray and/or lung CT scan~PATIENT CHARACTERISTICS:~Age:~* 16 and under at diagnosis~Performance status:~* Not specified~Life expectancy:~* Not specified~Hematopoietic:~* Not specified~Hepatic:~* Not specified~Renal:~* Not specified~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Not specified~Chemotherapy:~* Not specified~Endocrine therapy:~* Not specified~Radiotherapy:~* Not specified~Surgery:~* See Disease Characteristics~* Prior surgery allowed

- Gender: ALL
- Minimum Age: None
- Maximum Age: 16 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).